GLP-1 receptor agonists , such as semaglutide (Wegovy) and liraglutide (Saxenda), are currently among the most studied agents in people with CKD
Ben Greenfield: Okay, gotcha
Growth/differentiation factor-15 (GDF-15) Another potential therapeutic pathway for obesity pharmacotherapies is through the stress-induced cytokine GDF-15, which is expressed in multiple cell types including cardiomyocytes, adipocytes and macrophages [98]
Side Effects of L-Carnitine Safe for most people
For KAP (ketamine-assisted psychotherapy), your provider is in the room with you
Labs (as appropriate): A1c or fasting glucose, lipids, kidney and liver function